Henry Luzze
About
Henry Luzze is a scholar working on Infectious Diseases, Health and Epidemiology.
According to data from OpenAlex, Henry Luzze has authored 29 papers receiving a total of 630 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 15 papers in Health and 15 papers in Epidemiology. Recurrent topics in Henry Luzze's work include Vaccine Coverage and Hesitancy (15 papers), Tuberculosis Research and Epidemiology (10 papers) and Pneumocystis jirovecii pneumonia detection and treatment (7 papers). Henry Luzze is often cited by papers focused on Vaccine Coverage and Hesitancy (15 papers), Tuberculosis Research and Epidemiology (10 papers) and Pneumocystis jirovecii pneumonia detection and treatment (7 papers). Henry Luzze collaborates with scholars based in Uganda, United States and United Kingdom. Henry Luzze's co-authors include Alphonse Okwera, John L. Johnson, Zahra Toossi, Moses Joloba, Jerrold J. Ellner, Roy D. Mugerwa, Christina S. Hirsch, Alison M. Elliott, Maria Quigley and Christopher C. Whalen and has published in prestigious journals such as PLoS ONE, Journal of Virology and The Journal of Infectious Diseases.
In The Last Decade
Henry Luzze
25 papers receiving 616 citations
Peers
Henry Luzze
Anne Wajja Uganda
Muki Shey South Africa
Sapna Bamrah Morris United States
Shu‐Hsing Cheng Taiwan
Elisa López‐Varela Spain
Morten Bjerregaard-Andersen Guinea-Bissau
Lydia Nakiyingi Uganda
Gerrit‐Jan Weverling Netherlands
Jorge Luján‐Zilbermann United States
Marie‐Luce Delforge Belgium
Citations per year, relative to Henry Luzze Henry Luzze (= 1×)
peers
Anne Wajja
Countries citing papers authored by Henry Luzze
Since
Specialization
Citations
This map shows the geographic impact of Henry Luzze's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henry Luzze with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henry Luzze more than expected).
Fields of papers citing papers by Henry Luzze
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Henry Luzze. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henry Luzze. The network helps show where Henry Luzze may publish in the future.
Co-authorship network of co-authors of Henry Luzze
This figure shows the co-authorship network connecting the top 25 collaborators of Henry Luzze. A scholar is included among the top collaborators of Henry Luzze based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henry Luzze. Henry Luzze is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Che, Primus, Henry Luzze, Alison M. Elliott, et al.. (2025). Assessing community vulnerability to reduced vaccine impact in Uganda and Kenya: A spatial data analysis. NIHR Open Research. 5. 24–24.
2.
Che, Primus, et al.. (2025). Mapping Community Vulnerability to reduced Vaccine Impact in Uganda and Kenya: A spatial Data-driven Approach. NIHR Open Research. 5. 24–24.
3.
Thekkur, Pruthu, Selma Dar Berger, Stavia Turyahabwe, et al.. (2025). Case Finding Among and Comprehensive Management of Household Contacts of Persons with Pulmonary Tuberculosis: a Pilot Project — Uganda, 2023–2024. MMWR Morbidity and Mortality Weekly Report. 74(9). 145–151.
4.
Nuwematsiko, Rebecca, Noah Kiwanuka, Solomon Tsebeni Wafula, et al.. (2024). Pre-diagnosis and pre-treatment loss to follow-up and associated factors among patients with presumed tuberculosis and those diagnosed in Uganda. BMC Health Services Research. 24(1). 1638–1638.
5.
Kaawa–Mafigiri, David, et al.. (2021). A qualitative study of the development and utilization of health facility-based immunization microplans in Uganda. Health Research Policy and Systems. 19(S2). 52–52.
6.
Ehlman, Daniel C., Aaron S. Wallace, Prosper Behumbiize, et al.. (2020). Evaluating a Mobile Phone–Delivered Text Message Reminder Intervention to Reduce Infant Vaccination Dropout in Arua, Uganda: Protocol for a Randomized Controlled Trial. JMIR Research Protocols. 10(2). e17262–e17262.
7.
Nkurunungi, Gyaviira, Jacent Nassuuna, Gloria Oduru, et al.. (2020). Population differences in vaccine responses (POPVAC): scientific rationale and cross-cutting analyses for three linked, randomised controlled trials assessing the role, reversibility and mediators of immunomodulation by chronic infections in the tropics. BMJ Open. 11(2). e040425–e040425.
8.
Ward, Kirsten, Steven Stewart, Melissa Wardle, et al.. (2019). Building health workforce capacity for planning and monitoring through the Strengthening Technical Assistance for routine immunization training (START) approach in Uganda. Vaccine. 37(21). 2821–2830.
9.
Nsubuga, Fred, et al.. (2019). Comparing static and outreach immunization strategies and associated factors in Uganda, Nov-Dec 2016. Pan African Medical Journal. 32. 123–123.
10.
Ward, Kirsten, Adam MacNeil, Henry Luzze, et al.. (2019). Financial cost analysis of a strategy to improve the quality of administrative vaccination data in Uganda. Vaccine. 38(5). 1105–1113.
11.
Luzze, Henry, et al.. (2017). Understanding the policy environment for immunization supply chains: Lessons learned from landscape analyses in Uganda and Senegal. Vaccine. 35(17). 2141–2147.
12.
Mukonzo, Jackson, Alphonse Okwera, Henry Luzze, et al.. (2013). Influence of efavirenz pharmacokinetics and pharmacogenetics on neuropsychological disorders in Ugandan HIV-positive patients with or without tuberculosis: a prospective cohort study. BMC Infectious Diseases. 13(1). 261–261.
13.
Sekandi, Juliet N., Justin M. List, Henry Luzze, et al.. (2013). Yield of undetected tuberculosis and human immunodeficiency virus coinfection from active case finding in urban Uganda. The International Journal of Tuberculosis and Lung Disease. 18(1). 13–19.
14.
Luzze, Henry, Denise F. Johnson, Kathleen G. Dickman, et al.. (2013). Relapse more common than reinfection in recurrent tuberculosis 1–2 years post treatment in urban Uganda. The International Journal of Tuberculosis and Lung Disease. 17(3). 361–367.
15.
Mayanja‐Kizza, Harriet, Mianda Wu, Htin Aung, et al.. (2009). The Interaction of Monocyte Chemoattractant Protein‐1 and Tumour Necrosis Factor‐α in Mycobacterium tuberculosis‐induced HIV‐1 Replication at Sites of Active Tuberculosis. Scandinavian Journal of Immunology. 69(6). 516–520.
16.
Elliott, Alison M., Henry Luzze, Maria Quigley, et al.. (2004). A Randomized, Double‐Blind, Placebo‐Controlled Trial of the Use of Prednisolone as an Adjunct to Treatment in HIV‐1–Associated Pleural Tuberculosis. The Journal of Infectious Diseases. 190(5). 869–878.
17.
Luzze, Henry, Alison M. Elliott, Moses Joloba, et al.. (2001). Evaluation of suspected tuberculous pleurisy: clinical and diagnostic findings in HIV-1-positive and HIV-negative adults in Uganda.. PubMed. 5(8). 746–53.
18.
Hirsch, Charles S., Zahra Toossi, John L. Johnson, et al.. (2001). Augmentation of Apoptosis and Interferon‐γ Production at Sites of ActiveMycobacterium tuberculosisInfection in Human Tuberculosis. The Journal of Infectious Diseases. 183(5). 779–788.
19.
Mayanja‐Kizza, Harriet, John L. Johnson, Charles S. Hirsch, et al.. (2001). Macrophage‐Activating Cytokines in Human Immununodeficiency Virus Type 1–Infected and –Uninfected Patients with Pulmonary Tuberculosis. The Journal of Infectious Diseases. 183(12). 1805–1809.
20.
Luzze, Henry, Maria Quigley, Jacqueline Kyosiimire–Lugemwa, et al.. (2001). HIV-1-related pleural tuberculosis: elevated production of IFN-γ, but failure of immunity to Mycobacterium tuberculosis. AIDS. 15(4). 467–475.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Anne Wajja Breakdown of academic impact, for papers by Muki Shey Breakdown of academic impact, for papers by Sapna Bamrah Morris Breakdown of academic impact, for papers by Shu‐Hsing Cheng Breakdown of academic impact, for papers by Elisa López‐Varela Breakdown of academic impact, for papers by Morten Bjerregaard-Andersen Breakdown of academic impact, for papers by Lydia Nakiyingi Breakdown of academic impact, for papers by Gerrit‐Jan Weverling Breakdown of academic impact, for papers by Jorge Luján‐Zilbermann Breakdown of academic impact, for papers by Marie‐Luce Delforge